NasdaqCM - Delayed Quote USD
Delcath Systems, Inc. (DCTH)
At close: November 4 at 4:00 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-31,374.00
-31,251.00
-24,950.00
-22,604.00
-22,868.00
Investing Cash Flow
-4,725.00
-19,709.00
-209.00
-143.00
-782.00
Financing Cash Flow
36,244.00
51,778.00
10,143.00
20,822.00
42,355.00
End Cash Position
14,735.00
12,696.00
11,822.00
26,953.00
28,756.00
Interest Paid Supplemental Data
--
1,459.00
1,873.00
681.00
11.00
Capital Expenditure
-132.00
-58.00
-209.00
-143.00
-782.00
Issuance of Capital Stock
6,922.00
23,083.00
10,857.00
3,923.00
39,764.00
Issuance of Debt
--
--
--
14,437.00
--
Repayment of Debt
-6,107.00
-6,313.00
-714.00
--
-26.00
Free Cash Flow
-31,506.00
-31,309.00
-25,159.00
-22,747.00
-23,650.00
12/31/2020 - 5/3/2018
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
MYO Myomo, Inc.
3.8300
+2.41%
CLPT ClearPoint Neuro, Inc.
12.74
-1.16%
LNSR LENSAR, Inc.
5.86
+8.92%
LUNG Pulmonx Corporation
7.12
+13.56%
CTSO Cytosorbents Corporation
0.8705
-12.95%
AXGN Axogen, Inc.
14.20
+1.79%
NVNO enVVeno Medical Corporation
3.3900
+1.19%
ECOR electroCore, Inc.
12.32
+6.85%
CVRX CVRx, Inc.
15.05
+12.31%
SRTS Sensus Healthcare, Inc.
6.36
-3.20%